135 related articles for article (PubMed ID: 35035427)
1. Immunohistochemical Expression of MMP-9 and E-Cadherin in subtypes of Ameloblastoma.
Farhan F; Niazi Z; Masood S; Abbas B
Pak J Med Sci; 2022; 38(1):207-213. PubMed ID: 35035427
[TBL] [Abstract][Full Text] [Related]
2. IMMUNOEXPRESSION OF TWIST IN DIFFERENT MORPHOLOGICAL VARIANTS OF AMELOBLASTOMAS.
Khalil E; Rehman A; Ahmed F
J Ayub Med Coll Abbottabad; 2015; 27(2):296-303. PubMed ID: 26411101
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9 (mmp-9) expression in different subtypes of ameloblastoma.
Anne R; Krisnuhoni E; Chotimah C; Latief BS
J Maxillofac Oral Surg; 2014 Sep; 13(3):281-5. PubMed ID: 25018601
[TBL] [Abstract][Full Text] [Related]
4. Unicystic Ameloblastoma of Mandible with an Unusual Diverse Histopathology: A Rare Case Report.
Jain K; Sharma G; Kardam P; Mehendiratta M
J Clin Diagn Res; 2017 Apr; 11(4):ZD04-ZD05. PubMed ID: 28571285
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of MMP-9, TIMP-2, E-cadherin and vimentin in ameloblastomas and their implication in the local aggressive behavior of these tumors.
Florescu A; Mărgăritescu C; Simionescu CE; Stepan A
Rom J Morphol Embryol; 2012; 53(4):975-84. PubMed ID: 23303021
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Detection of p75 Neurotrophin Receptor (p75-NTR) in Follicular and Plexiform Ameloblastoma.
Ragunathan YT; Madhavan NR; Mohan SP; Kumar SK
J Clin Diagn Res; 2016 Aug; 10(8):ZC63-6. PubMed ID: 27656566
[TBL] [Abstract][Full Text] [Related]
7. Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas.
Carreón-Burciaga RG; González-González R; Molina-Frechero N; López-Verdín S; Pereira-Prado V; Bologna-Molina R
Anal Cell Pathol (Amst); 2018; 2018():9392632. PubMed ID: 29850393
[TBL] [Abstract][Full Text] [Related]
8. MMP-7, -8, -9, E-cadherin, and beta-catenin expression in 34 ameloblastoma cases.
Kelppe J; Thorén H; Haglund C; Sorsa T; Hagström J
Clin Exp Dent Res; 2021 Feb; 7(1):63-69. PubMed ID: 32985799
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Detection of Nerve Growth Factor (NGF) in Follicular and Plexiform Ameloblastoma - A Novel Study.
Yoithapprabhunath TR; Renugadevi S; Ganapathy N; Dineshshankar J; Yamunadevi A; Nirmal RM
J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S569-S575. PubMed ID: 33149523
[TBL] [Abstract][Full Text] [Related]
11. Ameloblastoma: biological profile of 3677 cases.
Reichart PA; Philipsen HP; Sonner S
Eur J Cancer B Oral Oncol; 1995 Mar; 31B(2):86-99. PubMed ID: 7633291
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of Tyrosine Kinase receptor (TrK) in follicular and plexiform ameloblastoma - A novel study.
Jisha GB; Ilayaraja V; Yoithapprabhunath TR; Ganapathy N; Dineshshankar J; Nirmal RM
J Oral Maxillofac Pathol; 2020; 24(1):125-130. PubMed ID: 32508460
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of Nuclear Factor-kappa B (NF-κB) between follicular and plexiform ameloblastomas: A pilot study.
Sivakumar M; Yoithapprabhunath TR; Nirmal RM; Veeravarmal V; Dineshshankar J; Amsaveni R
J Oral Maxillofac Pathol; 2020; 24(3):466-471. PubMed ID: 33967482
[TBL] [Abstract][Full Text] [Related]
14. Interplay Between MMP-9 and TIMP-2 Regulates Ameloblastoma Behavior and Tooth Morphogenesis.
Nunia K; Urs AB; Kumar P
Appl Immunohistochem Mol Morphol; 2016; 24(5):364-72. PubMed ID: 26067137
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of E-cadherin and beta-catenin in ameloblastomas and tooth germs.
Alves Pereira KM; do Amaral BA; dos Santos BR; Galvão HC; Freitas Rde A; de Souza LB
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):425-31. PubMed ID: 20219600
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of bone remodeling molecules expression in different types of jaw ameloblastoma.
Iakovou M; Chrysomali E; Piperi E; Fanourakis G; Sklavounou A; Vlachodimitropoulos D; Tseleni-Balafouta S
J Oral Pathol Med; 2015 Aug; 44(7):543-51. PubMed ID: 25243582
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Prevalence and Clinical Features of Ameloblastoma and its Histopathological Subtypes in Southeast Myanmar and Lower Northern Thailand Populations: A 13-Year Retrospective Study.
Intapa C
J Clin Diagn Res; 2017 Jan; 11(1):ZC102-ZC106. PubMed ID: 28274056
[TBL] [Abstract][Full Text] [Related]
18. The dilemma of extensive unilocular radiolucent lesions of the jaws - value of immunohistochemistry as a diagnostic marker and prognostic Indicator.
Jeyaraj P
Ann Diagn Pathol; 2019 Jun; 40():105-135. PubMed ID: 31077874
[TBL] [Abstract][Full Text] [Related]
19. Mural unicystic ameloblastoma with multifarious histopathological patterns: An exquisite case report.
Ahmed SP; Gunasekaran N; Arunachalam P; Annasamy RK
Indian J Dent Res; 2020; 31(5):803-806. PubMed ID: 33433524
[TBL] [Abstract][Full Text] [Related]
20. A combination of follicular and plexiform ameloblastoma: A rare case report.
Kajla P; Lata J; Aggarwal S
Natl J Maxillofac Surg; 2022 Aug; 13(Suppl 1):S212-S215. PubMed ID: 36393941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
